Shinichiro Yamada
University of Tokushima
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Shinichiro Yamada.
Hepatology Research | 2012
Shinichiro Yamada; Mitsuo Shimada; Hidenori Miyake; Tohru Utsunomiya; Yuji Morine; Satoru Imura; Tetsuya Ikemoto; Hiroki Mori; Jun Hanaoka; Shuichi Iwahashi; Yu Saito
Aim: The aim of this study was to investigate the characteristics of super‐elderly hepatocellular carcinoma (HCC) patients aged 80 years or more who underwent hepatectomy and to clarify whether elderly patients with HCC benefit from hepatectomy.
Journal of Hepato-biliary-pancreatic Sciences | 2014
Yu Saito; Mitsuo Shimada; Tohru Utsunomiya; Tetsuya Ikemoto; Shinichiro Yamada; Yuji Morine; Satoru Imura; Hiroki Mori; Yusuke Arakawa; Mami Kanamoto; Shuichi Iwahashi; Chie Takasu
Whether systemically transplanted human adipose‐derived stem cells (ADSCs) homed to the injured liver in nude mice under stress with subsequent hepatectomy (Hx) and ischemia‐reperfusion (I/R) was investigated in the present study. The types of cells in the liver that were involved in the homing of ADSCs were clarified, with focus on the stromal‐derived factor‐1 (SDF‐1)/C‐X‐C chemokine receptor type 4 (CXCR‐4) axis.
Hepatology Research | 2014
Tohru Utsunomiya; Daichi Ishikawa; Michihito Asanoma; Shinichiro Yamada; Shuichi Iwahashi; Mami Kanamoto; Yusuke Arakawa; Tetsuya Ikemoto; Yuji Morine; Satoru Imura; Hiroki Ishibashi; Chie Takasu; Mitsuo Shimada
It is reasonable to investigate non‐tumor liver tissues to predict a risk for development of hepatocellular carcinoma (HCC). A molecular analysis of chronically damaged liver tissues may identify specific miRNA expression profiles associated with a risk for multicentric (MC) HCC.
Hepatology Research | 2012
Yu Saito; Mitsuo Shimada; Tohru Utsunomiya; Yuji Morine; Satoru Imura; Tetsuya Ikemoto; Hiroki Mori; Jun Hanaoka; Shinichiro Yamada; Michihito Asanoma
Aim: Lens culinaris agglutinin A‐reactive fraction of α‐fetoprotein (AFP‐L3) status has been reported to be an independent prognostic factor in patients with hepatocellular carcinoma (HCC). In this study, we evaluated the clinical usefulness of measuring preoperative AFP‐L3 to predict the recurrence and prognosis of HCC after curative hepatectomy.
Journal of Gastroenterology and Hepatology | 2015
Chinbold Enkhbold; Yuji Morine; Tohru Utsunomiya; Satoru Imura; Tetsuya Ikemoto; Yusuke Arakawa; Yu Saito; Shinichiro Yamada; Daichi Ishikawa; Mitsuo Shimada
A remarkable feature of the liver is its regenerative capacity following partial hepatectomy. However, the regenerative capacity of many organs and tissues loses its natural ability to divide with aging. In this study, we investigated the association of aging with endoplasmic reticulum stress, the cell cycle, autophagy, and apoptosis‐related genes during liver regeneration after hepatectomy.
Journal of Gastroenterology and Hepatology | 2016
Gizachew Yismaw Wubetu; Mitsuo Shimada; Yuji Morine; Tetsuya Ikemoto; Daichi Ishikawa; Shuichi Iwahashi; Shinichiro Yamada; Yu Saito; Yusuke Arakawa; Satoru Imura
The long‐term survival of patients with hepatocellular carcinoma remains unsatisfactory because of the presence of cancer stem cells (CSCs), which are responsible for tumor recurrence and chemoresistance after hepatectomy. Drugs that selectively target CSCs thus offer great promise for cancer treatment. Although the antitumor effects of epigallocatechin gallate (EGCG) have been reported in some cancer cells, its effects on CSCs remain poorly studied. In this study, we investigated the effects of EGCG on human hepatoma and colon CSCs.
Journal of Gastroenterology and Hepatology | 2014
Chengzhan Zhu; Tetsuya Ikemoto; Tohru Utsunomiya; Shinichiro Yamada; Yuji Morine; Satoru Imura; Yusuke Arakawa; Chie Takasu; Daichi Ishikawa; Mitsuo Shimada
Liver regeneration likely decreases with age by an, as yet, incompletely understood mechanism, restricting the extent of hepatectomy. We therefore analyzed the effect of aging on liver regeneration and investigated mechanisms associate with poor regeneration of human liver.
Cancer Letters | 2016
Shuichi Iwahashi; Mitsuo Shimada; Tohru Utsunomiya; Satoru Imura; Yuji Morine; Tetsuya Ikemoto; Chie Takasu; Yu Saito; Shinichiro Yamada
We reported that poor prognoses of hepatocellular carcinoma (HCC) patients after radiofrequency ablation (RFA) are owing to up-regulation of expression of hypoxia-inducible factor-1 and epithelial cell adhesion molecule. We investigated aggressive progression in residual liver tumors (RLTs) after RFA to focus on expression of epithelial-mesenchymal transition (EMT)-related genes and miRNAs. Ten patients with recurrent HCC post-RFA who underwent hepatectomy (RFA group) and 78 patients with HCC without prior RFA (non-RFA group) were enrolled. We examined expression of transforming growth factor (TGF)-β, Twist, vimentin, and Snail-1 mRNAs in tumor tissues, and expression of miR-34a and miR-200c. Expression of TGF-β, Twist and Snail-1 in the RFA group was significantly higher than that in the non-RFA group (P < 0.05); vimentin expression in the RFA group was higher than that in the non-RFA group (P = 0.07). Expression of miR-200c and miR-34a in the RFA group was significantly lower than that in the non-RFA group (miR-200c: P = 0.04; miR-34a: P < 0.01). Increased expression of EMT markers through down-regulation of miRNA expression in RLTs after RFA may be related to poor prognoses of HCC patients with aggressive local recurrence after RFA.
Journal of Gastroenterology and Hepatology | 2014
Satoru Imura; Lkhagva-Ochir Tovuu; Tohru Utsunomiya; Yuji Morine; Tetsuya Ikemoto; Yusuke Arakawa; Mami Kanamoto; Shuichi Iwahashi; Yu Saito; Chie Takasu; Shinichiro Yamada; Daichi Ishikawa; Yoshimi Bando; Mitsuo Shimada
Fbxw7 is a tumor suppressor gene through ubiquitination and degradation of multiple oncoproteins. Loss of Fbxw7 expression is frequently observed in various human cancers. In the present study, we examined the role of Fbxw7 expression in both non‐tumor liver tissues and tumor tissues on clinicopathological significance.
Pancreas | 2013
Tetsuya Ikemoto; Mitsuo Shimada; Masato Komatsu; Shinichiro Yamada; Yu Saito; Hiroki Mori; Yuji Morine; Satoru Imura; Yoshimi Bando; Tohru Utsunomiya
Objective Intraductal papillary mucinous neoplasms (IPMNs) have a high malignant potential. We previously reported that peripheral Foxp3+CD4+CD25+ T-cell (Foxp3+ Treg) populations significantly increase with IPMN pathological aggressiveness. Dendritic cell-mediated induction of active Tregs from naive CD4+ T cells requires indoleamine 2,3-dioxygenase (IDO). Here, we evaluated whether an IDO–Foxp3+ Treg interaction plays a role in IPMN pathological aggressiveness. Methods We evaluated peripheral blood samples and resected specimens from 12 patients with IPMN. We analyzed Foxp3+CD4+CD25+ T cells in peripheral blood by fluorescence-activated cell sorting, evaluated the resected specimens by anti-IDO antibody staining, and compared them with the patients’ clinicopathological factors. Results The pathological aggressiveness of IPMN was significantly associated with the number of peripheral Foxp3+ Tregs (P < 0.05) and IDO-positive cells per high-power field (HPF) (P < 0.01). There was a significant correlation between the numbers of peripheral Foxp3+ Tregs and IDO-positive cells/HPF (r = 0.625, P < 0.01). Patients with 7 or more IDO-positive cells/HPF had a significantly higher recurrence rate than those with less than 7 IDO-positive cells/HPF (P < 0.01, log-rank test). Conclusions Peripheral Foxp3+ Tregs accurately reflect the aggressiveness of IPMNs. An increase in Foxp3+ Tregs can be induced by local IDO-positive cells in IPMN.